Table 2.
Complications during hospitalization and association with ICU admission in ECRMC COVID-19 patients
| Admission complications* | Total n (%) |
No ICU n (%) |
ICU admission n (%) |
p-value |
|---|---|---|---|---|
| N = 156 | n = 94 | n = 62 | ||
| Respiratory failure in the emergency department** | 132 (84.6) | 77 (81.9) | 55 (88.7) | 0.2497 |
| Acute kidney injury‡‡ | 46 (30.5) | 12 (12.9) | 34 (73.9) | < 0.0001 |
| Dialysis‡‡ | 21 (13.9) | 9 (42.9) | 12 (57.1) | 0.0572 |
| Cardiovascular and coagulopathy complications‡‡‡ | 37 (100) | 13 (13.8) | 24 (38.7) | 0.0004 |
| Outcome | ||||
| Mortality | ||||
| Survived | 126 (85.1) | 87 (93.6) | 39 (70.9) | 0.0002 |
| Died | 22 (14.9) | 6 (6.4) | 16 (29.1) | |
| Missing | 8 | 1 | 7 | |
*Column percents are reported
**Any signs or symptoms of the respiratory failure which was addressed in the ED. These include nasal cannula, non-breather mask, bi-level positive pressure ventilation, hi-flow, or intubation
***Unable to perform reliable chi-square analysis due > 25% cells with missing data when analyzed with the individual oxygen
‡Patient was considered a hospice patient
‡‡AKI and dialysis data missing a total of 5 patients, 1 non-ICU, 4 ICU patients
‡‡‡Cardiovascular and coagulopathic complications including those requiring anticoagulants for specific treatment of CVA, cardiac ischemia (elevated troponin), atrial fibrillation/arrhythmias, DVT/PE, or other coagulopathies during admission